Active not recruitingNAINTERVENTIONAL

WATER IV Prostate Cancer

At a glance

Status

Active not recruiting

Phase

Sponsor

PROCEPT BioRobotics

Enrolment target

280

Start

03 Feb 2025

Estimated completion

01 Jan 2037

Localized Prostate Cancer

What is this study about?

This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to either Aquablation Therapy or radical prostatectomy and followed up to 10 years.

Who may be eligible?

Age 45 Years to any · Sex: MALE

Locations (37)

Arizona State Urological Institute
Chandler, United States
East Valley Urology Center
Mesa, United States
University of Southern California
Los Angeles, United States
Boulder Medical Center
Boulder, United States
Advanced Research
Delray Beach, United States
University of Miami
Miami, United States
Florida Urology Partners
Tampa, United States
Trophy Point Urology
Tampa, United States
Georgia Urology
Atlanta, United States
Mountain View Hospital
Idaho Falls, United States
University of Chicago
Chicago, United States
Endeavor Health
Glenview, United States

+25 more sites — see the official record for the full list.

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.